MILLER VALUE PARTNERS, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 234 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLER VALUE PARTNERS, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2013$645,000
+5.9%
76,4000.0%0.03%
-21.6%
Q3 2013$609,000
+3.2%
76,4000.0%0.04%
-9.8%
Q2 2013$590,00076,4000.04%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2014
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders